Hepatitis B Infection clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
- Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
- HepB mAb19 in Individuals With Chronic Hepatitis B Infection
- Liver Cancer Disparities in American Indian and Alaska Native Persons
- National Liver Cancer Screening Trial
- Adaptability of an Undetectable = Untransmissible Model for HBV
- Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
- The DC Cohort Longitudinal HIV Status Neutral Study
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
- Blood Collection Biorepository for Liver Disease Research
- Evaluation of Patients With Liver Disease
- Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
- HIV/HBV/HCV Triple Screening in Primary Care
- Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
- Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
- The HOPE Study: Characterizing Patients With Hepatitis B and C
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hepatitis B Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.